SUVN-1507035

N/A

Report date: 2025/01/26 16:37:33
NME

Base Information

Drug NameSUVN-1507035
Drug Alias NameSUVN-1507035
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor modulatorsSerotonin 1a (5-HT1a) receptor modulatorsDopamine D2 receptor modulators +[4] 
TargetsSerotonin 2a (5-HT2a) receptorAlpha-1b adrenergic receptorDopamine D2 receptor +[4] 
Therapy Area/IndicationsPsychotic DisordersDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSuven Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuven Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsPsychotic DisordersDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A